Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.941
+0.021 (1.09%)
At close: Nov 13, 2026, 4:00 PM EST
1.920
-0.021 (-1.08%)
After-hours: Nov 13, 2026, 7:30 PM EST
Propanc Biopharma Employees
Propanc Biopharma had 2 employees as of June 30, 2026. The number of employees did not change compared to the previous year. That makes Propanc Biopharma the 43,719th largest employer in the world and 7,250th in the United States.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$11,772,689
Market Cap
1.23M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | 0 | - | 2 | 0 |
| Jun 30, 2025 | 2 | 0 | - | 1 | 1 |
| Jun 30, 2024 | 2 | 0 | - | 1 | 1 |
| Jun 30, 2023 | 2 | -1 | -33.33% | 1 | 1 |
| Jun 30, 2022 | 3 | 1 | 50.00% | 1 | 2 |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PMGC Holdings | 34 |
| Enlivex | 34 |
| Aptevo Therapeutics | 33 |
| Genprex | 13 |
| Artelo Biosciences | 7 |
| Kairos Pharma | 4 |
| 60 Degrees Pharmaceuticals | 3 |
| SciSparc | 3 |
PPCB News
- 1 day ago - Propanc Biopharma Quarterly report: Q1 2027 - Filings
- 12 days ago - Propanc Biopharma reports preclinical PRP data - TheFly
- 12 days ago - Propanc Biopharma Reports Preclinical Data with PRP & PRP plus TGF-β Inhibitor on TGF-β Pathway in Pancreatic Cancer - GlobeNewsWire
- 15 days ago - Propanc Biopharma Advances Bioanalytical & Immunogenicity Assay Development for Phase 1b First-In-Human Study in up to 50 Advanced Cancer Patients - GlobeNewsWire
- 17 days ago - Propanc Biopharma targets February start for first-in-human cancer study - TheFly
- 17 days ago - Propanc Biopharma Advances Clinical Development Preparation for PRP Phase 1b First-In-Human Study in Up to 50 Advanced Cancer Patients - GlobeNewsWire
- 19 days ago - Propanc Biopharma announces new PRP preclinical data - TheFly
- 19 days ago - Propanc Biopharma Publishes New Data: PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells & Restores Therapeutic Vulnerability - GlobeNewsWire